Below are the most recent publications written about "Artemisinins" by people in Profiles.
-
Connelly SV, Muller JG, Ali M, Ngasala BE, Hassan W, Mohamed B, Thwai KL, Sadler JM, Marglous J, Fola AA, Zacharia A, Shija SJ, Mohammed S, C Msolo D, Said H, Peter EE, Odas M, Rutha IJ, Nwange M, Naire K, Ruybal-Pes?ntez S, Verity R, Crudale R, Goel V, Choloi BB, Bj?rkman A, Bailey JA, Lin JT, Juliano JJ. Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023. J Infect Dis. 2026 Feb 18; 233(2):e491-e495.
-
Zeleke AJ, Fola AA, Tollefson GA, Niar? K, Leonetti A, Taropawala O, Marglous J, Crudale R, Brhane BG, Assefa A, Kiyuka P, Parr JB, Hailu A, Tegegne MA, Bailey JA. High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLoS Pathog. 2025 Dec; 21(12):e1013771.
-
Gashema P, Jordan A, Saramba E, Wernsman Young N, Iradukunda PG, Karema C, Mazarati JB, Juliano JJ, Bailey JA, Banek K. Understanding Malaria Treatment Adherence in Rwanda: Implications for Artemisinin Resistance. Am J Trop Med Hyg. 2025 Dec 03; 113(6):1279-1288.
-
Martin AC, Sadler JM, Simkin A, Musonda M, Katowa B, Matoba J, Schue J, Simulundu E, Bailey JA, Moss WJ, Juliano JJ, Fola AA. Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia. J Infect Dis. 2025 Oct 15; 232(4):918-922.
-
Meier-Scherling CPG, Watson OJ, Asua V, Ghinai I, Katairo T, Garg S, Conrad MD, Rosenthal PJ, Okell LC, Bailey JA. Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling study. Lancet Microbe. 2025 May; 6(5):101027.
-
Wernsman Young N, Gashema P, Giesbrecht D, Munyaneza T, Maisha F, Mwebembezi F, Budodo R, Leonetti A, Crudale R, Iradukunda V, Jean Bosco N, Kirby RI, Boyce RM, Mandara CI, Kanyankole GK, Ntaro M, Okell LC, Watson OJ, Mulogo E, Ishengoma DS, Hangi S, Karema C, Mazarati JB, Juliano JJ, Bailey JA. High Frequency of Artemisinin Partial Resistance Mutations in the Great Lakes Region Revealed Through Rapid Pooled Deep Sequencing. J Infect Dis. 2025 Feb 04; 231(1):269-280.
-
Okitwi M, Shoue DA, Checkley LA, Orena S, Ceja FG, Taremwa Y, Tumwebaze PK, Katairo T, Byaruhanga O, Sievert MA, Garg S, Kreutzfeld OK, Legac J, Bailey JA, Nsobya SL, Conrad MD, Rosenthal PJ, Ferdig MT, Cooper RA. The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates. Antimicrob Agents Chemother. 2024 12 05; 68(12):e0118324.
-
Fola AA, Kobayashi T, Hamapumbu H, Musonda M, Katowa B, Matoba J, Stevenson JC, Norris DE, Thuma PE, Wesolowski A, Moss WJ, Juliano JJ, Bailey JA. Temporal genomics in Southern Zambia shows rising prevalence of Plasmodium falciparum mutations linked to delayed clearance after artemisinin-lumefantrine treatment. Sci Rep. 2024 11 05; 14(1):26789.
-
Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, Francis F, Buguzi CC, Moshi R, Garimo I, Lazaro S, Lusasi A, Aaron S, Chacky F, Mohamed A, Njau RJA, Kitau J, Rasmussen C, Bailey JA, Juliano JJ, Warsame M. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. Lancet Infect Dis. 2024 11; 24(11):1225-1233.
-
Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, Bakari C, Madebe RA, Seth MD, Mandara CI, Popkin-Hall ZR, Moshi R, Mbwambo RB, Niar? K, MacInnis B, Francis F, Mbwambo D, Garimo I, Chacky F, Aaron S, Lusasi A, Molteni F, Njau RJA, Nhiga SL, Mohamed A, Bailey JA, Ishengoma DS. Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13?regions in Tanzania in 2021: a cross-sectional survey. Lancet Microbe. 2024 10; 5(10):100920.